Oragenics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1996-01-01
- Employees
- 11
- Market Cap
- $7M
- Website
- http://www.oragenics.com
Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day
- First Posted Date
- 2017-07-31
- Last Posted Date
- 2020-11-23
- Lead Sponsor
- Oragenics, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT03234465
- Locations
- 🇺🇸
University of Connecticut Health Center, Farmington, Connecticut, United States
🇺🇸Comprehensive Cancer Centers of Nevada-Henderson, Henderson, Nevada, United States
🇺🇸East Carolina Univ School of Dental Medicine, Greenville, North Carolina, United States
Effect of an Oral Probiotic Tablet on Oral Bacteria and Clinical Measurements (ProBiora3)
- First Posted Date
- 2012-01-30
- Last Posted Date
- 2012-05-02
- Lead Sponsor
- Oragenics, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT01520974
- Locations
- 🇺🇸
University of Washington, Scool of Dentistry, Regional Clinical Dental Research Center, Seattle, Washington, United States
© Copyright 2024. All Rights Reserved by MedPath